“Hormone Therapy and the Women’s Health Initiative: lessons we have learnt, moving forward with an evidence-based approach”   GP & HP Professional Development Activity Professor Helena Teede and Professor Henry Burger present an update for general practitioners and health professionals on “Hormone Therapy and the Women’s Health Initiative: lessons we have learnt, moving forward with an evidence-based approach”.

Professor Helena Teede Director of Research, the Jean Hailes Foundation for Women's Health and also with the Department of Medicine Monash University and Endocrinologist. Professor Henry Burger Board Director, Jean Hailes Foundation for Women's Health Prince Henry's Institute of Medical Research

View the On-demand Webcast http://jeanhailes.streamcast.com.au/1_console_hi.html http://jeanhailes.streamcast.com.au/1_console_lo.html Note: The Livial and Breast Cancer study referred to in this presentation has ceased. Results from the study are expected to be released late 2008. For CPD points download and print the evaluation form, complete and fax back. Your certificate will then be sent to you. CPD applications will be processed for members of the RACGP and ACRRM.  Hormone Therapy Webcast Slides (453.00 KB)  Hormone Therapy Webcast Evaluation Form (474.50 KB)

Webcast Requirements You will also need a PC or Macintosh computer with sound capabilities, Internet connection and Internet Explorer 4 or later to view this on-demand webcast presentation. High band and low band versions are available. Total program time 1 hour 20 minutes  Parts may be viewed separately.

Program Outline

Part 1: Therapies for Menopausal Symptoms: Update, Professor Helena Teede (28 minutes)

Part 2: Why the Women’s Health Initiative was wrongly interpreted, Professor Henry Burger (32 minutes)

Part 3: Venous Thromboembolic Disease, Alzheimer's Disease and Hormone Therapy, Professor Helena Teede (20 minutes)

Points Available

RACGP: Allocated 3 points (Category 2 - Women's Health) in the RACGP QA&CPD Program for the 2008-2010 triennium

ACRRM: Accredited with the ACRRM PDP program for 2 points core

RANZCOG: Fellows of RANZCOG can claim 1 point per hour for educational activities under the RANZCOG CPD self-education category.

References used in Webcast

Ettinger B et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999 Aug 18;282(7):637-645. Erratum in: JAMA 1999 Dec 8;282(22):2124.

Pilote L and Hlatky MA. Attitudes of women toward hormone therapy and prevention of heart disease. Amer Heart J 1995 Jun;129:1237-8.

Chlebowski RT et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 2003 Jun 25;289:3243-3253.

Questions and Answers

If you have a question you would like to put to these presenters simply email: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it and a response will be shown below (no personal details will be shown).  

For further information  please contact:
The Jean Hailes Foundation for Women’s Health 1800 151 441 or
email:  This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Questions and Answers from the Webcast

Note: No personal details will be shown.
           Questions and Answers are not intended for the discussion or
           transmission of personal and confidential medical information. 
           Please review our Privacy Statement.

Content updated July 2, 2008